EUCTR2008-003803-30-IT进行中（未招募）不适用
Effects of the treatment with metformin and/or sitagliptin on ß- cell function and insulin resistance in women with prior gestational diabetes. - ND
AZIENDA OSPEDALIERA PISANA0 个研究点开始时间: 2011年2月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •1. Women between 18 and 50; 2. caucasian race; 3. positive anamnesis for gestational diabet in the previous pregnancy, fulfilled for at least 1 year; 4. diagnosis of previous GDM defined according to Carpenter and Coustan criteria, i.e. FPG value = 126 mg/dl and/or two or more of the following condition after a 100-g oral glucose load in the oral glucose tolerance test (OGTT)0`? = 95 mg/dl, 60`? = 180 mg/dl, 120`? = 155 mg/dl, 180`? = 140 mg/dl;5. Use of an efficacious contraceptive method for at least 1 month and for all study duration; 6. written consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Previous diagnosis of DM type 1 and/or positivity of autoantibodies anti pancreatic insules (anti-GAD, anti-IA2); 2. diagnosis of DM in the 75-g OGTT, performed at entry, defined as a FPG value = 126 mg/dl and/or a PG value = 200 mg/dl 2 hours after the glucose load; 3. BMI< 18 kg/m2 or > 50 kg/m2; 4. chronic impaired renal function; 5. total hemoglobin rate < 12 g/dl 6. impaired liver function as shown by transaminase level = twice above the upper normal range; 7. breast-feeding women; 8. pregnant women, or women planning to become pregnant during the study, 9. history of hypersensitivity to metformin; 10. failure to use adequate contraception (women of current reproductive potential only); 11. mental condition rendering the subject unable to understand the nature, scope and possible consequences of the study; 12. any clinically significant major organ system disease such as relevant cardiovascular, gastrointestinal, hepatic, neurological, endocrine, heamatological or other major systemic disease or infective diseases making implementation of the protocol or interpretation of the study results difficult; 13. patient with underlying concomitant medication requiring a long-term use of drug potentially acting on glucose metabolism (e.g. corticosteroids, diuretics, or others); 14. hisory of drug or alcohol abuse within the last two years or current addiction to substances of abuse, 15. any disease or condition that in the opinion of investigator may interfere with the completion of the study.
研究者
相似试验
暂停
1 期
A Randomised Double-Blind Controlled Trial of Metformin and Atorvastatin – with treatment commenced following prostatic biopsy and ceasing just before radical prostatectomy - to guide subsequent patient managementCancer - ProstateProstate cancerACTRN12615000571572niversity of Queensland Centre for Clinical Research80
招募中
3 期
empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20220822055771N1Shahre-kord University of Medical Sciences50
已完成
不适用
Comparison of therapeutic effects of metformin and simvastatin in PCOSPCOS.Polycystic ovarian syndromeIRCT201012285487N2Alzahra Hospital Research Center60
招募中
3 期
Effect of using metformin on the incidence of gestational diabetes and preeclampsia in pregnant women with polycystic ovaryPre-eclampsiaIRCT20120215009014N252Hamedan University of Medical Sciences170
已完成
不适用
The effect of metformin and insulin in the prevention of preeclampsiaPre-eclampsiaIRCT20220107053652N1Esfahan University of Medical Sciences150